Return On Equity of Minerva Neurosciences, Inc. from 31 Mar 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Minerva Neurosciences, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2015 to 30 Sep 2025.
  • Minerva Neurosciences, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 46%, a 357% increase year-over-year.
  • Minerva Neurosciences, Inc. annual Return On Equity for 2024 was -4%, a 103% decline from 2023.
  • Minerva Neurosciences, Inc. annual Return On Equity for 2023 was 137%, a 54% decline from 2022.
  • Minerva Neurosciences, Inc. annual Return On Equity for 2022 was 296%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Minerva Neurosciences, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 46% +36% +357% 01 Jul 2025 30 Sep 2025
Q2 2025 -41% -145% -140% 01 Apr 2025 30 Jun 2025
Q1 2025 -21% -150% -116% 01 Jan 2025 31 Mar 2025
Q4 2024 -4% -141% -103% 01 Oct 2024 31 Dec 2024
Q3 2024 10% -130% -93% 01 Jul 2024 30 Sep 2024
Q2 2024 104% -42% -29% 01 Apr 2024 30 Jun 2024
Q1 2024 130% -40% -23% 01 Jan 2024 31 Mar 2024
Q4 2023 137% -159% -54% 01 Oct 2023 31 Dec 2023
Q3 2023 140% -1074% -88% 01 Jul 2023 30 Sep 2023
Q2 2023 146% +874% 01 Apr 2023 30 Jun 2023
Q1 2023 169% +454% 01 Jan 2023 31 Mar 2023
Q4 2022 296% +466% 01 Oct 2022 31 Dec 2022
Q3 2022 1214% +1302% 01 Jul 2022 30 Sep 2022
Q2 2022 -728% -655% -904% 01 Apr 2022 30 Jun 2022
Q1 2022 -285% -295% -2966% 01 Jan 2022 31 Mar 2022
Q4 2021 -170% -174% -4171% 01 Oct 2021 31 Dec 2021
Q3 2021 -89% -37% -73% 01 Jul 2021 30 Sep 2021
Q2 2021 -72% -6% -8.6% 01 Apr 2021 30 Jun 2021
Q1 2021 10% +172% 01 Jan 2021 31 Mar 2021
Q4 2020 4% +131% 01 Oct 2020 31 Dec 2020
Q3 2020 -51% +25% +33% 01 Jul 2020 30 Sep 2020
Q2 2020 -67% -3% -4.8% 01 Apr 2020 30 Jun 2020
Q1 2020 -162% -106% -187% 01 Jan 2020 31 Mar 2020
Q4 2019 -127% -79% -167% 01 Oct 2019 31 Dec 2019
Q3 2019 -76% -45% -141% 01 Jul 2019 30 Sep 2019
Q2 2019 -64% -34% -118% 01 Apr 2019 30 Jun 2019
Q1 2019 -56% -29% -104% 01 Jan 2019 31 Mar 2019
Q4 2018 -47% -20% -75% 01 Oct 2018 31 Dec 2018
Q3 2018 -32% +6% +15% 01 Jul 2018 30 Sep 2018
Q2 2018 -29% +7% +19% 01 Apr 2018 30 Jun 2018
Q1 2018 -28% +3% +8.4% 01 Jan 2018 31 Mar 2018
Q4 2017 -27% +4% +11% 01 Oct 2017 31 Dec 2017
Q3 2017 -37% -3% -10% 01 Jul 2017 30 Sep 2017
Q2 2017 -36% 0% -0.06% 01 Apr 2017 30 Jun 2017
Q1 2017 -30% +16% +34% 01 Jan 2017 31 Mar 2017
Q4 2016 -31% +11% +26% 01 Oct 2016 31 Dec 2016
Q3 2016 -34% +7% +17% 01 Jul 2016 30 Sep 2016
Q2 2016 -36% +39% +52% 01 Apr 2016 30 Jun 2016
Q1 2016 -46% +68% +60% 01 Jan 2016 31 Mar 2016
Q4 2015 -41% 01 Oct 2015 31 Dec 2015
Q3 2015 -41% 01 Jul 2015 30 Sep 2015
Q2 2015 -75% 01 Apr 2015 30 Jun 2015
Q1 2015 -113% 01 Jan 2015 31 Mar 2015

Minerva Neurosciences, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -4% -141% -103% 01 Jan 2024 31 Dec 2024
2023 137% -159% -54% 01 Jan 2023 31 Dec 2023
2022 296% +466% 01 Jan 2022 31 Dec 2022
2021 -170% -174% -4173% 01 Jan 2021 31 Dec 2021
2020 4% +131% 01 Jan 2020 31 Dec 2020
2019 -127% -79% -167% 01 Jan 2019 31 Dec 2019
2018 -47% -20% -75% 01 Jan 2018 31 Dec 2018
2017 -27% +4% +11% 01 Jan 2017 31 Dec 2017
2016 -31% +11% +26% 01 Jan 2016 31 Dec 2016
2015 -41% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.